Announcement
11 Jun 2026
: M42’s IROS Launches UAE’s First Genomics-Driven Clinical Trial to Prevent Alzheimer’s Disease
Learn More

Decoding Clinico Genomics from Population Scale to Precision Therapies

29 January 2024
Genomics and Precision Medicine

About the Speakers

  • Albarah El Khani
    Chief Operating Officer, Integrated Health Solutions, M42
  • Dr. Stephen Grobmyer
    Chairman of Oncology at Cleveland Clinic Abu Dhabi
  • Dr. Fawad Khan
    Program Lead of the Hereditary High Risk & Cancer Survivorship Programs at the Oncology Institute, Cleveland Clinic Abu Dhabi
  • Dr. Val Zvereff
    Laboratory Director at M42

    Watch Next